Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone Iontophoresis in Psoriasis
NCT03979664Phase 1Withdrawn
- Sponsor
- Wake Forest University Health Sciences
- Start
- Mar 2021
- Primary completion
- Dec 2021
- Modality
- Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of dexamethasone iontophoretic patch in psoriasis (2 arms), sponsored by Wake Forest University Health Sciences. Primary endpoint: Static Physician Global Assessment at 2 weeks. Planned start Mar 2021; status: withdrawn.
02
Drugs
dexamethasone iontophoretic patch
03
Conditions
psoriasis
Beyond the preview
Go deeper on NCT03979664.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03979664.